Given the general amplified immune response early after LNP-CTNNB1 treatment, we next investigated potential tumor cell-intrinsic molecular mechanisms driving the immune excluded phenotype in β-catenin-mutated HCCs. Here, CTNNB1 is linked to neoplasm.